Related Experiment Video

Updated: Aug 23, 2026

A Pre-Clinical Model of Synovitis Using Ex vivo Human Synovial Tissue with Preserved Function and Architecture
08:32

A Pre-Clinical Model of Synovitis Using Ex vivo Human Synovial Tissue with Preserved Function and Architecture

Published on: March 20, 2026

N-acetyl cysteine regulates TNF-alpha-inhibited differentiation in ROS 17/2.8 osteoblasts

Han-Jung Chae1, Soo-Wan Chae, Hyung-Ryong Kim

  • 1Department of Pharmacology and Institute of Cardiovascular Research, School of Medicine, Chonbuk National University, Chonbuk, South Korea.

Immunopharmacology and Immunotoxicology
|June 24, 2004
PubMed

Insights

Tumor necrosis factor-alpha inhibits osteoblast differentiation by activating NF-kappaB. N-acetyl cysteine prevents this by targeting IkappaB degradation, highlighting NF-kappaB

Area of Science:

  • Bone biology and cellular differentiation.
  • Molecular mechanisms of inflammation in osteoblasts.

Background:

  • Osteoblasts are crucial for bone remodeling.
  • Tumor necrosis factor-alpha (TNF-alpha) is implicated in bone pathologies.
  • TNF-alpha can negatively impact osteoblast function.

Purpose of the Study:

  • To investigate the effect of TNF-alpha on osteoblast differentiation.
  • To elucidate the role of NF-kappaB signaling in TNF-alpha-induced inhibition of osteoblasts.
  • To explore the potential of N-acetyl cysteine (NAC) as a therapeutic agent.

Main Methods:

  • Treatment of ROS 17/2.8 osteoblasts with varying concentrations of TNF-alpha.
  • Assessment of alkaline phosphatase (ALPase) activity as a marker of differentiation.
  • Measurement of NF-kappaB DNA binding activity using nuclear extracts.
  • Evaluation of IkappaB alpha and IkappaB beta degradation.
  • Generation and analysis of IkappaB (KD)-stably transfected ROS 17/2.8 cells.

Main Results:

  • TNF-alpha significantly decreased ALPase activity, indicating inhibited osteoblast differentiation.
  • TNF-alpha treatment increased NF-kappaB DNA binding activity.
  • N-acetyl cysteine (NAC) completely prevented TNF-alpha-induced NF-kappaB activation.
  • TNF-alpha caused rapid degradation of IkappaB alpha and IkappaB beta.
  • IkappaB (KD) transfectants showed no regulation of ALPase, suggesting IkappaB alpha's importance.

Conclusions:

  • NF-kappaB activation, mediated by IkappaB alpha and IkappaB beta degradation, is a key mechanism by which TNF-alpha inhibits osteoblast differentiation.
  • NAC effectively blocks TNF-alpha's detrimental effects on osteoblasts by targeting the IkappaB/NF-kappaB pathway.
  • NF-kappaB is a critical regulator of osteoblast differentiation in the context of TNF-alpha exposure.

More Related Videos

Effect of Anti-c-fms Antibody on Osteoclast Formation and Proliferation of Osteoclast Precursor In Vitro07:51

Effect of Anti-c-fms Antibody on Osteoclast Formation and Proliferation of Osteoclast Precursor In Vitro

Published on: March 18, 2019

Differentiation of Functional Osteoclasts from Human Peripheral Blood CD14+ Monocytes11:52

Differentiation of Functional Osteoclasts from Human Peripheral Blood CD14+ Monocytes

Published on: January 27, 2023

Related Concept Videos

T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...